The Effects of the Combined Therapy of Acupuncture and Yoga Exercise on Weight Loss
To Evaluate the Effects of Weight-loss by the Combined Therapy of Acupuncture and Yoga Exercise
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Kuender D. Yang, PhD
- Phone Number: 886-975617006
- Email: yehshuhui@gmail.com
Study Locations
-
-
-
Changhua County, Taiwan
- Recruiting
- Division of Core Laboratory; Chang Bing Show Chwan Memorial Hospital
-
Contact:
- Kuender D. Yang, PhD
- Phone Number: 886-975617006
- Email: yangkd.yeh@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI > 24
Exclusion Criteria:
- Diagnosis of cancer.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Other: Acupuncture controls
Acupuncture group will receive 30-minutes treatment three times a week for 3 months.
|
Acupuncture about 30 mins will be performed by a traditional Chinese physician three times a week for 3 months.
|
|
Experimental: acupuncture and yoga exercise
Subject will receive a combination of acupuncture and yoga exercise three times a week for 3 months.
|
Acupuncture about 30 mins will be performed by a traditional Chinese physician three times a week for 3 months.
Subject will receive regular 60-minutes yoga exercise three times a week for 3 months.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduce body mass index.
Time Frame: Change from baseline in body mass index at 3 months
|
Outcome measure compares the change in body mass index during 3 months treatment.
|
Change from baseline in body mass index at 3 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduce waistline
Time Frame: Change from baseline in waistline at 3 months
|
Outcome measure compares the change in waistline during 3 months treatment.
|
Change from baseline in waistline at 3 months
|
|
Change biochemical profile of blood
Time Frame: Change from baseline in biochemical profile of blood at 3 months
|
Outcome measure compares the changes in biochemical profile of blood including cholesterol/high-density lipoprotein/low-density lipoprotein/blood sugar during 3 months treatment.
Peripheral blood will be collected at 2 different times.
(1) baseline data: before intervention, (2) outcome data: at 3 months post-intervention.
|
Change from baseline in biochemical profile of blood at 3 months
|
|
Immune modulation
Time Frame: Change from baseline in lymphocyte profile and polarization at 3 months
|
Immune function will be assessed by blood analysis including lymphocyte subpopulations (Th1/ Th2/ Treg/ Th17), polarization (T-bet/ Gata-3/ Foxp3/ RORrt), its related cytokines (Th1: IL-12/ IFN-γ/ IL-27; Th2: IL-4/ IL-13/ IL-25; Th17: IL-17A/ IL-6/ IL-21; Treg: TGF-β/ IL-10) during 3 months treatment.
Peripheral blood will be collected at 2 different times.
(1) baseline data: before intervention, (2) outcome data: at 3 months post-intervention.
|
Change from baseline in lymphocyte profile and polarization at 3 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Kuender D. Yang, PhD., Chang Bing Show Chwan Memorial Hospital
- Study Director: Shu-Hui Yeh, PhD., Chang Bing Show Chwan Memorial Hospital & Central Taiwan University of Science and Technology
- Principal Investigator: Yu-Kwan Lu, MD., Show Chwan Memorial Hospital
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 1011003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.